Prevention of parenteral nutrition-associated liver disease in children

Stuart S Kaufman1

  • 1Pediatric Intestinal Transplantation Medicine, The Mount Sinai Hospital and Medical School, New York 10029-6574, USA. stuart.kaufman@mountsinai.org

Insights

Parenteral nutrition can cause liver injury, ranging from mild to severe liver failure, especially in patients with massive intestinal resection. Management involves enteral nutrition, sepsis control, and potentially restricting lipid emulsions.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Clinical Nutrition

Background:

  • Parenteral nutrition (PN) is linked to liver injury, with severity varying widely.
  • Severe PN-related liver disease often occurs in patients with massive intestinal resection.
  • Sepsis and inflammation play a key role in the progression of PN-associated liver injury.

Purpose of the Study:

  • To describe the spectrum of liver injury associated with parenteral nutrition.
  • To outline the clinical presentation and management strategies for PN-related liver disease.
  • To differentiate liver failure in short bowel syndrome from that in anatomically normal GI tracts.

Main Methods:

  • Review of clinical presentations and outcomes in patients with PN-associated liver disease.
  • Analysis of factors contributing to liver injury progression, including sepsis and inflammation.
  • Comparison of clinical features of liver failure in short bowel syndrome versus normal GI tracts.

Main Results:

  • Liver injury severity is not solely dependent on PN duration or delayed enteral feeding.
  • Enteral nutrition, sepsis management, and bacterial overgrowth control are crucial treatments.
  • Advanced liver failure in short bowel syndrome presents with hyperbilirubinemia and hepatosplenomegaly, differing from typical liver failure.

Conclusions:

  • PN-related liver disease management requires a multifaceted approach.
  • Early intervention for sepsis and inflammation is critical.
  • Intestinal and/or liver transplantation may be the best option for long-term survival in severe cases.

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...